Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Department of Pain Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Front Immunol. 2023 Aug 24;14:1209282. doi: 10.3389/fimmu.2023.1209282. eCollection 2023.
Rapidly progressive interstitial lung disease (RP-ILD) is the most serious complication of anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5 DM). This study was performed to assess the prognostic factors of patients with anti-MDA5 DM and the clinical characteristics and predictors of anti-MDA5 DM in combination with RP-ILD.
In total, 73 MDA5 DM patients were enrolled in this study from March 2017 to December 2021. They were divided into survival and non-survival subgroups and non-RP-ILD and RP-ILD subgroups.
The lactate dehydrogenase (LDH) concentration and prognostic nutritional index (PNI) were independent prognostic factors in patients with anti-MDA5 DM: the elevated LDH was associated with increased mortality ( = 0.01), whereas the elevated PNI was associated with reduced mortality ( < 0.001). The elevated LDH was independent risk prognostic factor for patients with anti-MDA5 DM (HR 2.42, 95% CI: 1.02-4.83, p = 0.039), and the elevated PNI was independent protective prognostic factor (HR, 0.27; 95% CI, 0.08 - 0.94; = 0.039). Patients who had anti-MDA5 DM with RP-ILD had a significantly higher white blood cell count and LDH concentration than those without RP-ILD ( = 0.007 and = 0.019, respectively). In contrast, PNI was significantly lower in patients with RP-ILD than those without RP-ILD ( < 0.001). The white blood cell count and elevated LDH were independent and significant risk factors for RP-ILD (OR 1.54, 95% CI: 1.12 - 2.13, p = 0.009 and OR 8.68, 95% CI: 1.28 - 58.83, p = 0.027, respectively), whereas the lymphocyte was an independent protective factor (OR, 0.11; 95% CI, 0.01 - 0.81; = 0.03).
The elevated LDH and elevated PNI were independent prognostic factors for patients with anti-MDA5 DM. The elevated LDH was independent risk factor for RP-ILD. Patients with anti-MDA5 DM could benefit from the measurement of LDH and PNI, which are inexpensive and simple parameters that could be used for diagnosis as well as prediction of the extent of lung involvement and prognosis.
快速进展性间质性肺病(RP-ILD)是抗黑色素瘤分化相关基因 5 阳性皮肌炎(抗-MDA5 DM)最严重的并发症。本研究旨在评估抗-MDA5 DM 患者的预后因素,以及抗-MDA5 DM 合并 RP-ILD 的临床特征和预测因素。
本研究共纳入 2017 年 3 月至 2021 年 12 月期间的 73 例 MDA5 DM 患者,将其分为存活和非存活亚组、非 RP-ILD 和 RP-ILD 亚组。
乳酸脱氢酶(LDH)浓度和预后营养指数(PNI)是抗-MDA5 DM 患者的独立预后因素:LDH 升高与死亡率增加相关( = 0.01),而 PNI 升高与死亡率降低相关( < 0.001)。LDH 升高是抗-MDA5 DM 患者的独立风险预后因素(HR 2.42,95%CI:1.02-4.83,p = 0.039),而 PNI 升高是独立的保护预后因素(HR,0.27;95%CI,0.08 - 0.94; = 0.039)。合并 RP-ILD 的抗-MDA5 DM 患者的白细胞计数和 LDH 浓度明显高于无 RP-ILD 的患者( = 0.007 和 = 0.019)。相比之下,合并 RP-ILD 的患者的 PNI 明显低于无 RP-ILD 的患者( < 0.001)。白细胞计数和 LDH 升高是 RP-ILD 的独立且显著的危险因素(OR 1.54,95%CI:1.12 - 2.13,p = 0.009 和 OR 8.68,95%CI:1.28 - 58.83,p = 0.027),而淋巴细胞是独立的保护因素(OR,0.11;95%CI,0.01 - 0.81; = 0.03)。
LDH 和 PNI 升高是抗-MDA5 DM 患者的独立预后因素。LDH 升高是 RP-ILD 的独立危险因素。抗-MDA5 DM 患者可从 LDH 和 PNI 的测量中获益,这些参数简单且价格低廉,可用于诊断以及预测肺部受累程度和预后。